Device Trial Radar · NCT05404880
INSPIRIS China PMCF Study
Last checked: Nov 20, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
255
Actual
Start
Jul 13, 2022
Primary completion
Mar 2034
Study completion Dec 2034
Sponsor
- Lead sponsor
- Edwards LifesciencesPublic (EW)
- Sponsor type
- Industry
- Collaborators
- Edwards (Shanghai) Lifesciences Medical Supplies Co., Ltd.; Rundo International Pharmaceutical Research & Development Co.,Ltd.; Chinese Academy of Medical Sciences, Fuwai Hospital
- First posted
- Jun 3, 2022
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this post-market trial is to evaluate long term safety and performance of the Edwards Lifesciences INSPIRIS RESILIA aortic valve in Chinese patients in a real-world clinical setting.
Conditions
- Aortic Valve Replacement
Interventions
EDWARDS INSPIRIS RESILIA Aortic ValveDevice
Surgical replacement of the aortic valve with the INSPIRIS RESILIA Aortic Valve.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Subject's Occurrence Rate of Study Valve Related DeathTime frame: 10 Years
- Subject's Occurrence Rate of Structural Valve DeteriorationTime frame: 10 Years
- Subject's Occurrence Rate of Re-operation on the Study ValveTime frame: 10 Years
5 more outcomes with a free account
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Fuwai Hospital, CAMS & PUMC
Beijing, Beijing Municipality, China
Xiamen Cardiovascular Hospital Xiamen University
Xiamen, Fujian, China
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.